Income Statement
IMMUNOCORE HOLDINGS PLC
IMCR
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Revenue
|
400.02 | 310.20 | 249.43 |
|
Cost of Revenue
|
5.09 | 2.73 | 1.04 |
|
Gross Profit
|
394.93 | 307.47 | 248.39 |
|
Operating Expenses
|
440.28 | 377.93 | 308.04 |
|
Research & Development
|
274.87 | 222.15 | 163.55 |
|
Selling, General & Administrative
|
165.41 | 155.78 | 144.50 |
|
Other Operating Expenses
|
- | - | - |
|
Operating Income
|
-45.35 | -70.46 | -59.65 |
|
Non-Operating Income
|
-26.25 | -17.52 | 1.24 |
|
Interest Income
|
16.48 | 25.62 | 17.99 |
|
Interest Expense
|
12.17 | 18.84 | 5.15 |
|
Other Non-Op Income / Expense
|
19.73 | 14.20 | -0.90 |
|
Income Before Tax
|
43.19 | 16.26 | 11.61 |
|
Income Tax Expense
|
16.41 | -1.85 | -5.60 |
|
Non-Controlling Interest
|
- | - | - |
|
Net Income
|
-35.51 | -51.09 | -55.29 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY |
|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - |
|
EBITDA
|
-45.35 | -70.46 | -59.65 |
|
Earnings Per Share (Basic)
|
-0.71 | -1.02 | -1.13 |
|
Diluted EPS
|
-0.71 | -1.02 | -1.13 |
|
Weighted Average Shares
|
50.35 | 49.99 | 48.89 |
|
Diluted Weighted Avg Shares
|
50.35 | 49.99 | 48.89 |
|
Comprehensive Income
|
-29.84 | -48.59 | -36.88 |